+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market

  • ID: 5345766
  • Report
  • June 2021
  • Region: Global
  • 11 Pages
  • Life Science Intelligence

FEATURED COMPANIES

  • Boston Scientific/Symetis
  • Direct Flow Medical
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • NVT

This report from the publisher provides the latest market data for the Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market. Information covered by this report includes:

  • unit volumes & pricing forecast from 2020-2025
  • analyses of the leading companies, and
  • global market share analysis.

This report covers the impact of COVID-19 on heart valve replacement procedures, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, and others. The report provides insights into trends, drivers, and limiters of the transcatheter aortic heart valves market, as well as highlights potential opportunities.

Companies Covered

  • Boston Scientific/Symetis
  • Direct Flow Medical
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • NVT
  • Portico
  • Transcatheter Technologies
Note: Product cover images may vary from those shown
  • Boston Scientific/Symetis
  • Direct Flow Medical
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • NVT
  • Portico
  • Transcatheter Technologies
Note: Product cover images may vary from those shown
Adroll
adroll